Abhay Kumar

Abhay Kumar is a seasoned professional in business development and licensing, currently serving as the Senior Director at Aldevron since August 2022, where the focus is on the cell and gene therapy market. Previously, Abhay held roles at Beckman Coulter Life Sciences as Senior Staff in Strategy and Open Innovation, and at Thermo Fisher Scientific in Strategic Business Development, where responsibilities included forming long-term partnerships and assessing growth opportunities. With extensive experience at Life Technologies in various leadership positions related to corporate development and licensing, and early career roles at Hybritech Incorporated, Abhay has a strong background in technology sourcing and immunodiagnostics. Abhay's academic accomplishments include an MBA from San Diego State University, a post-doctoral fellowship at Baylor College of Medicine, and a Ph.D. in Veterinary Microbiology and Public Health.